Highlights Lupin Limited

Equities

LUPIN

INE326A01037

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-06-10 am EDT			5-day change	1st Jan Change
1,636 ^INR	+0.43%		+3.30%	+23.67%

Jun. 05	Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada	MT
May. 30	India's pharma export sales to grow faster this year, trade body says	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada	Jun. 05	MT
India's pharma export sales to grow faster this year, trade body says	May. 30	RE
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research	May. 27	RE
Lupin Gets Six Observations from US FDA After Somerset Unit Inspection	May. 20	MT
Lupin's Consolidated Profit Climbs in Fiscal Q4; Shares Dip 4%	May. 07	MT
Indian drugmaker Lupin misses quarterly profit estimates as costs rise	May. 06	RE
Lupin Limited Board Recommends Dividend for the Year Ended March 31, 2024	May. 06	CI
Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 06	CI
Lupin Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 06	CI
Lupin Limited Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP	May. 06	CI
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility	Apr. 23	MT
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains	Apr. 22	RE
Lupin Launches Mirabegron Extended-Release Tablets in US	Apr. 21	MT
Lupin Limited Announces Launch of Mirabegron Extended-Release Tablets, 25 Mg, in the United States, After Having Received an Approval from the United States Food and Drug Administration	Apr. 20	CI
US FDA Clears Lupin's API Plant in Gujarat, India, Following GMP Inspection	Apr. 12	MT
Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US	Apr. 09	MT
Lupin Launches Generic Drug for Inflammatory Lesions of Rosacea in US	Apr. 09	MT
Lupin Limited Announces the Launch of First Generic Version of Oracea® (Doxycycline Capsules, 40 Mg), in the United States	Apr. 09	CI
Indian Equities Close with Marginal Loss on Wednesday as Traders Scale Down Hopes on US Rate Cuts	Apr. 03	MT
Lupin to Transfer Trade Generics Business to Subsidiary Lupin Life Sciences	Mar. 25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Lupin Limited

Equities

LUPIN

INE326A01037

Highlights

Filters